| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |